Moderna CCO cancels 10b5-1 trading plan; no trades executed

Moderna, Inc.

Arpa Garay, Chief Commercial Officer, adopted a 10b5-1 plan on August 24, 2023.
Plan cancelled on November 6, 2023, following disclosure of Q3 2023 results.
Sales under the plan were to begin no earlier than November 27; no shares sold or options exercised.

item 7.01

Moderna, Inc. filing history →

Source: SEC EDGAR

accession 0001682852-23-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.